Drepa-Opia: A Pilot Study to Determine the Predictive Factors of Morphine Use and Consumption in Hospitalized Adult Patients with Sickle Cell Disease

References

• Bardakdjian J, Wajcman H. [Epidemiology of sickle cell anemia] (French). Rev Prat. 2004;54(14):1531–1533.
   PubMedGoogle Scholar
• Ahmed SG. The role of infection in the pathogenesis of vaso-occlusive crisis in patients with sickle cell disease. Mediterr J Hematol Infect Dis. 2011;3(1):e2011028.
   PubMedGoogle Scholar
• Elenga N, Adeline A, Balcaen J, et al. Pregnancy in sickle cell disease is a very high-risk situation: an observational study. Obstet Gynecol Int. 2016;2016:9069054
   PubMed Web of Science ®Google Scholar
• Jones S, Duncan ER, Thomas N, et al. Windy weather and low humidity are associated with an increased number of hospital admissions for acute pain and sickle cell disease in an urban environment with a maritime temperate climate. Br J Haematol. 2005;131(4):530–533.
   PubMed Web of Science ®Google Scholar
• Yallop D, Duncan ER, Norris E, et al. The associations between air quality and the number of hospital admissions for acute pain and sickle-cell disease in an urban environment. Br J Haematol. 2007;136(6):844–848.
   PubMed Web of Science ®Google Scholar
• Ballas SK, Rubin RN, Gabuzda TC. Treating sickle cell pain like cancer pain. Ann Intern Med. 1992;117(3):263–264.
   PubMedGoogle Scholar
• Brandow AM, Nimmer M, Simmons T, et al. Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease. Am J Hematol. 2016;91(12):1175–1180.
   PubMed Web of Science ®Google Scholar
• Uzun B, Kekec Z, Gurkan E. Efficacy of tramadol vs meperidine in vasoocclusive sickle cell crisis. Am J Emerg Med. 2010;28(4):445–449.
   PubMed Web of Science ®Google Scholar
• Sickle cell acute painful episode: full guideline. NICE; 2012. Available from: https://www.nice.org.uk/guidance/cg143/evidence/full-guideline-186634333.
   Google Scholar
• Evidence-based management of sickle cell disease – Expert panel. National Institutes of Health – United States of America; 2014 [updated 2014; cited]; Available from: https://www.nhlbi.nih.gov/sites/www.nhlbi.nih.gov/files/sickle-cell-disease-report.pdf.
   Google Scholar
• Habibi A, Arlet JB, Stankovic K, et al. [French guidelines for the management of adult sickle cell disease: 2015 update]. Rev Med Interne 2015;36(5 Suppl 1):553–584.
   Google Scholar
• Solomon LR. Pain management in adults with sickle cell disease in a medical center emergency department. J Natl Med Assoc. 2010;102(11):1025–1032.
   PubMed Web of Science ®Google Scholar
• Tanabe P, Myers R, Zosel A, et al. Emergency department management of acute pain episodes in sickle cell disease. Acad Emerg Med. 2007;14(5):419–425.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Benjamin LJ, Payne R, et al. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage. 1997;14(3):168–174.
   PubMed Web of Science ®Google Scholar
• Waldrop RD, Mandry C. Health professional perceptions of opioid dependence among patients with pain. Am J Emerg Med. 1995;13(5):529–531.
   PubMed Web of Science ®Google Scholar
• Tanabe P, Artz N, Mark Courtney D, et al. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management. Acad Emerg Med. 2010;17(4):399–407.
   PubMed Web of Science ®Google Scholar
• Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol. 2005;79(1):17–25.
   PubMed Web of Science ®Google Scholar
• Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–1644.
   PubMed Web of Science ®Google Scholar
• Reddin CD, Cerrentano E, Tanabe P. Sickle cell disease management in the emergency department: what every emergency nurse should know. J Emerg Nurs. 2011;37(4):341–345.
   PubMed Web of Science ®Google Scholar
• Garcia-Morin M, Lopez-Sanguos C, Vazquez P, et al. Lactate dehydrogenase: a marker of the severity of vaso-occlusive crisis in children with sickle cell disease presenting at the emergency department. Hemoglobin 2016;40(6):388–391.
   PubMed Web of Science ®Google Scholar
• Najim OA, Hassan MK. Lactate dehydrogenase and severity of pain in children with sickle cell disease. Acta Haematol. 2011;126(3):157–162.
   PubMed Web of Science ®Google Scholar
• Stankovic Stojanovic K, Steichen O, Lefevre G, et al. High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients. Clin Biochem. 2012;45(18):1578–1582.
   PubMed Web of Science ®Google Scholar
• Joly P, Gagnieu MC, Bardel C, et al. Genotypic screening of the main opiate-related polymorphisms in a cohort of 139 sickle cell disease patients. Am J Hematol. 2012;87(5):534–536.
   PubMed Web of Science ®Google Scholar
• Rhodes MM, Bates DG, Andrews T, et al. Abdominal pain in children with sickle cell disease. J Clin Gastroenterol. 2014;48(2):99–105.
   PubMed Web of Science ®Google Scholar
• Chong SS, Boehm CD, Higgs DR, et al. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood 2000;95(1):360–362.
   PubMed Web of Science ®Google Scholar
• Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet. 2006;78(4):629–644.
   PubMed Web of Science ®Google Scholar
• Zempsky WT, Corsi JM, McKay K. Pain scores: are they used in sickle cell pain? Pediatr Emerg Care. 2011;27(1):27–28.
   PubMed Web of Science ®Google Scholar
• Galinski M, Dolveck F, Combes X, et al. Management of severe acute pain in emergency settings: ketamine reduces morphine consumption. Am J Emerg Med. 2007;25(4):385–390.
   PubMed Web of Science ®Google Scholar
• Anie KA, Egunjobi FE, Akinyanju OO. Psychosocial impact of sickle cell disorder: perspectives from a Nigerian setting. Global Health. 2010;6(2):2–6.
   PubMedGoogle Scholar
• Ballas SK, Darbari DS. Neuropathy, neuropathic pain, and sickle cell disease. Am J Hematol. 2013;88(11):927–929.
   PubMed Web of Science ®Google Scholar
• van Beers EJ, van Tuijn CF, Nieuwkerk PT, et al. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol. 2007;82(11):955–960.
   PubMed Web of Science ®Google Scholar
• Bartolucci P, Habibi A, Khellaf M, et al. Score predicting acute chest syndrome during vaso-occlusive crises in adult sickle-cell disease patients. EBioMedicine. 2016;10:305–311.
   PubMed Web of Science ®Google Scholar
• Birken CS, Khambalia A, Dupuis A, et al. Morphine is associated with acute chest syndrome in children hospitalized with sickle cell disease. Hosp Pediatr. 2013;3(2):149–155.
   PubMedGoogle Scholar
• Buchanan ID, Woodward M, Reed GW. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Pediatr Blood Cancer. 2005;45(5):716–724.
   PubMed Web of Science ®Google Scholar
• Kopecky EA, Jacobson S, Joshi P, et al. Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease. Clin Pharmacol Ther. 2004;75(3):140–146.
   PubMed Web of Science ®Google Scholar
• Lewing K, Britton K, DeBaun M, et al. The impact of parenteral narcotic choice in the development of acute chest syndrome in sickle cell disease. J Pediatr Hematol Oncol. 2011;33(4):255–260.
   PubMed Web of Science ®Google Scholar
• Charlot K, Romana M, Moeckesch B, et al. Which side of the balance determines the frequency of vaso-occlusive crises in children with sickle cell anemia: blood viscosity or microvascular dysfunction? Blood Cells Mol Dis. 2016;56(1):41–45.
   PubMed Web of Science ®Google Scholar
• Connes P, Renoux C, Romana M, et al. Blood rheological abnormalities in sickle cell anemia. Clin Hemorheol Microcirc. 2018;68(2-3):165–172.
   PubMed Web of Science ®Google Scholar
• Han J, Saraf SL, Zhang X, et al. Patterns of opioid use in sickle cell disease. Am J Hematol. 2016;91(11):1102–1106.
   PubMed Web of Science ®Google Scholar
• Ballas SK. The sickle cell painful crisis in adults: phases and objective signs. Hemoglobin 1995;19(6):323–333.
   PubMed Web of Science ®Google Scholar
• Ballas SK, Bauserman RL, McCarthy WF, et al. Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home. J Pain Symptom Manage. 2010;40(6):870–882.
   PubMed Web of Science ®Google Scholar
• Renoux C, Connes P, Nader E, et al. α-Thalassaemia promotes frequent vaso-occlusive crises in children with sickle cell anaemia through haemorheological changes. Pediatr Blood Cancer 2017;64(8):e26455. doi: 10.1002/pbc.26455.
   Web of Science ®Google Scholar
• Renoux C, Joly P, Faes C, et al. Association between oxidative stress, genetic factors, and clinical severity in children with sickle cell anemia. J Pediatr. 2018;195:228–235.
   PubMed Web of Science ®Google Scholar
• Brandow AM, Wandersee NJ, Dasgupta M, et al. Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use. Br J Haematol. 2016;175(2):237–245.
   PubMed Web of Science ®Google Scholar